The EAS Young Investigator Awards 2026 celebrate outstanding early-career researchers for their exceptional contributions to atherosclerosis and related metabolic disorders.
Each award, valued at €2,000, recognizes groundbreaking publications that advance scientific knowledge in these fields.
This year’s winners in both the Basic and Clinical categories will present their papers on the EAS Stage during the EAS Congress in Athens, Greece.
Don’t miss this opportunity to hear about their impactful work!
We are delighted to announce this year’s winners for their outstanding research:
Basic Science Award
Imidazole propionate is a driver and therapeutic target in atherosclerosis
Published in: Nature
Awardee: Annalaura Mastrangelo, Spanish National Center for Cardiovascular Research (CNIC)
Madrid, Spain
PMCID: PMC12408353
DOI: 10.1038/s41586-025-09263-w
Annalaura Mastrangelo is a researcher at the Spanish National Centre for Cardiovascular Research (CNIC) in Madrid in the laboratory of David Sancho. She received her international PhD in Medicinal Chemistry from Universidad San Pablo CEU in 2017, where she developed metabolomics approaches to identify metabolic signatures associated with metabolic and inflammatory diseases in human cohorts.
Her research focuses on microbiota‑derived metabolites and immunometabolic regulation in cardiovascular disease, integrating metabolomics with experimental and translational models to uncover mechanisms linking metabolism, immune activation, and atherosclerosis.
Clinical Science Award
First myocardial infarction: risk factors, symptoms, and medical therapy
Awardee: Nick Nurmohamed, Amsterdam UMC, Netherlands
Published in: European Heart Journal
PMCID: PMC12500329
DOI: 10.1093/eurheartj/ehaf390
Dr. Nick Nurmohamed earned his medical degree and PhD with highest honors from the University of Amsterdam and is currently training as a cardiologist at Amsterdam UMC. Supported by grants from the Dutch Heart Foundation and the European Atherosclerosis Society, his research focuses on advancing cardiovascular risk management through the use of novel biomarkers and state-of-the-art AI-guided coronary CT angiography.
Runners-up
In addition to the main awardees, the EAS Young Investigator Awards recognize outstanding contributions from runners-up in both the Basic and Clinical categories. Their exceptional research further advances our understanding of atherosclerosis and related metabolic disorders. Congratulations to this year’s runners-up for their impactful work!
Runners-up Basic Science Award
- Gut microbiota-dependent increase in phenylacetic acid induces endothelial cell senescence during aging
Published in: Nature Aging
Name: Soheil Saeedi, Schlieren, Switzerland
PMCID: PMC12176623
DOI: 10.1038/s43587-025-00864-8
- Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemia
Published in: Nature Cardiovascular Research
Name: Cesare Canepari, Milan, Italy
PMID: 41449803
DOI: 10.1016/j.ymthe.2025.12.036
Runners-up Clinical Science Award
- C-reactive protein and cardiovascular risk in the general population
Published in: European Heart Journal
Name: Berkan Kurt, Aachen, Germany
PMID: 41378999
DOI: 10.1093/eurheartj/ehaf937
- Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab
Published in: Atherosclerosis
Name: Mark Atallah, Baltimore, United States
PMID: 40780143
DOI: 10.1016/j.atherosclerosis.2025.120469